ArticleNature communications2026

Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic targets in pancreatic cancer.

Feng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.